react: effect of celecoxib vs placebo as adjuvant therapy on dfs among patients with breast cancer
Published 2 years ago • 186 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
7:41
the react trial: celecoxib vs placebo for primary breast cancer
-
2:12
the impact of adjuvant chemo on os in hr and node bc with an oncotype dx score of 25 or less
-
5:02
samuraciclib in combination with fulvestrant in patients with advanced hr /her2- breast cancer
-
0:59
comparing and sequencing t-dm1 and t-dxd in her2 breast cancer
-
2:01
chemotherapy in patients with luminal breast cancer and an intermediate risk recurrence score
-
2:22
analysis of assay used in impassion130 to guide treatmeant of metastatic and advanced breast can...
-
6:16
proof 301: infigratinib vs. gem/cis in patients with cca with an fgfr2 gene fusion/rearrangement
-
3:59
repurposing ms and nmosd treatments for cidp
-
6:36
evaluation of transfusion reactions
-
2:01
assess facial muscle reactions-experienced & observed affective touch in humans l protocol preview
-
2:02
prognosis comparison of different molecular subtypes of breast tumors - video abstract [id 213663]
-
1:03
azd2014 for treating er metastatic breast cancer – mode of action and trial results
-
1:25
genomic profiling for defining luminal subtypes
-
1:11
results of trial of ribociclib with everolimus and exemestane in breast cancer
-
0:32
quantitative confluency analysis: antibody drug conjugate (adcs) killing mouse breast cancer cells
-
4:32
results of quantum-first: quizartinib vs placebo plus intensive chemotherapy in flt3-itd aml
-
1:21
response-stratified chemoradiation enhances deep response rates in hnscc
-
47:39
2022 absite review breast
-
2:41
biospecimen assays (scientific standards hub)
-
1:47
the type i interferon response is suppressed in metastatic versus non-metastatic breast cancer
-
0:55
the clinical impact of gene expression assays on early luminal breast cancer